BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
May 17, 2010
 |  BC Week In Review  |  Company News  |  Deals

Angioblast Systems, Mesoblast deal

Mesoblast will acquire the 67% of partner Angioblast it does not already own in a stock deal. Angioblast shareholders will receive 94.6 million new Mesoblast shares, which are valued at A$183.5 million ($162.9 million) based on Mesoblast's close of A$1.94...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >